Regulatory
FDA Grants Fast Track to Faeth’s Metabolic Cancer Combo for Advanced Endometrial Cancer
PIKTOR, an oral combination that hits the PI3K/AKT/mTOR pathway, won fast-track status alongside chemotherapy for endometrial cancer that has progressed despite prior treatment.